Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00005095 · ClinicalTrials.gov registry record
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
A clinical trial of Ovarian Cancer and Endometrial Cancer, sponsored by Northwestern University.
- Recruiting
- Registry status
- 6,000
- Enrollment target
- 1
- Study location
NCT00005095 is a study of Ovarian Cancer and Endometrial Cancer that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 6,000 participants, above the 710-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (745% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00005095, a study of Ovarian Cancer and Endometrial Cancer, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- 6,000 participants
- Enrollment target
- 1
- Study location
Study Summary
RATIONALE: To improve strategies for detection and prevention of early-stage disease. PURPOSE: This research study is collecting specimens and data to develop better methods for early detection and prevention of ovarian cancer among the high risk population and those who have the disease.
Conditions Studied
Interventions
- PROCEDURE Surgery
- OTHER Ca-125
- OTHER screening questionnaire administration
Study Locations (1)
Illinois
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,000 participants |
| Start Date | 2000-03 |
| Est. Completion | 2040-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00005095
The ClinicalTrials.gov registry entry for NCT00005095 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 6,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 710-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (745% higher). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 9 conditions, with Ovarian Cancer appearing as the primary indexed condition, and to 3 interventions - of which Surgery is the first listed.
NCT00005095 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT00005095 about?
NCT00005095 is a clinical study titled "Specimen and Data Study for Ovarian Cancer Early Detection and Prevention". RATIONALE: To improve strategies for detection and prevention of early-stage disease. PURPOSE: This research study is collecting specimens and data to develop better methods for early detection and prevention of ovarian cancer among the high risk population and those who have the disease.
What is the current status of trial NCT00005095?
This trial is currently recruiting. The enrollment target is 6,000 participants. The study started on 2000-03. Estimated completion is 2040-12.
What conditions does trial NCT00005095 study?
This clinical trial studies the following conditions: Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Sarcoma, Fallopian Tube Cancer.
What interventions are being tested in trial NCT00005095?
The interventions under investigation include: Surgery (PROCEDURE), Ca-125 (OTHER), screening questionnaire administration (OTHER).
Who is sponsoring clinical trial NCT00005095?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00005095 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ovarian Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
RECRUITING · Phase 1
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Cognitive Impact of Neoadjuvant Chemotherapy for Ovarian Cancer
RECRUITING
-
The Better, Harder, Faster, Stronger Study
RECRUITING
-
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Bevacizumab in Adult Participants With Ovarian Cancer
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.